ArticleFrontiers in immunology2020

Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells.

Liangshun You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.